A coherent approach to rebooting drug discovery and design
Web Exclusives
Mind the gap
Proactively reducing long-term vaccine inequalities across Africa
Back to the future 3
A trio of trends that pharma needs to contend with in 2024
Craft work
Modelling the data revolution in clinical drug development
Precision decision
What to consider when evaluating UK, US or EU for MedTech markets
Future proofing
MHRA to recognise medicine approvals from trusted partner markets
Shape shifters
Transitioning from a linear to circular approach in sustainability
Molecular detail
For pharma necessity has always been the mother of invention
Long and winding road
The therapy trail from lab to patient is not for the faint-hearted
Identity parade
Across an intricate supply chain accuate labelling has never been more vital
Number blocks
How the pharma industry can navigate the data maelstrom
Gene genies
Ensuring broader access to life-changing gene therapies
Evolutionary tactic
Can synthetic human embryos really replace research animals?
Human beginning
Applying AI to your clinical resourcing strategy won’t end humankind
Getting the brand back together
Harnessing the power of an established identity is essential when navigating uncertainty across pharma
